Microsoft has avoided regulatory scrutiny in recent years. But its agreement to buy Activision Blizzard for $69 billion casts a new spotlight on the software giant. Read More...
Motley Fool
4 Pot Stocks to Avoid Like the Plague in 2022
While the industry is full of promising growth stocks, some of which are already achieving recurring profitability, the following four pot stocks, all of which have a Canadian focus, should be avoided like the plague in 2022. The award for the most times a pot stock has appeared on a “stocks to avoid list” unquestionably goes to Canadian licensed producer Aurora Cannabis (NASDAQ: ACB). Once upon a time, Aurora was the premier name among Canadian weed stocks.
Add Comment